Project Title
A risk-stratified trial for newly diagnosed patients with juvenile myelomonocytic leukemia
Layman’s summary
Juvenile Myelomonocytic Leukemia (JMML) is a type of blood cancer that typically affects infant and toddlers. It can be very challenging to identify and often requires multiple visits to the doctor before the diagnosis can be made. The only cure for this type of cancer is a stem cell transplant but it only works in half of the children that receive it. This clinical trial will give different intensities of treatment based on how aggressive an individual patient’s leukemia is. This is the first trial of its kind and will hopefully reduce side effects for some children with less aggressive JMML while offering new treatments to others how require more intensive therapy.
Elliot Stieglitz
This Project By The Numbers
